Literature DB >> 17853873

A protocol for imaging alternative splicing regulation in vivo using fluorescence reporters in transgenic mice.

Vivian I Bonano1, Sebastian Oltean, Mariano A Garcia-Blanco.   

Abstract

Imaging technologies are influencing the way we study regulatory processes in vivo. Several recent reports use fluorescence minigenes to image alternative splicing events in living cells and animals. This type of reporter is being used to generate transgenic mice to visualize splicing regulation in diverse tissues and cell types. In this protocol, we describe how to develop animals that report on alternative splicing and how to assess reporter expression in excised organs and tissue sections. The entire procedure, from making the reporters to imaging organs and tissues in adult transgenic mice, should take approximately 1.5 years. Fluorescence reporters can be used to image many splicing decisions in normal tissues and organs and can be extended to the study of disease states.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17853873     DOI: 10.1038/nprot.2007.292

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  17 in total

1.  Visualization and genetic analysis of alternative splicing regulation in vivo using fluorescence reporters in transgenic Caenorhabditis elegans.

Authors:  Hidehito Kuroyanagi; Genta Ohno; Hiroaki Sakane; Hiroyuki Maruoka; Masatoshi Hagiwara
Journal:  Nat Protoc       Date:  2010-08-05       Impact factor: 13.491

Review 2.  Networking in a global world: establishing functional connections between neural splicing regulators and their target transcripts.

Authors:  John A Calarco; Mei Zhen; Benjamin J Blencowe
Journal:  RNA       Date:  2011-03-17       Impact factor: 4.942

3.  A distal auxiliary element facilitates cleavage and polyadenylation of Dux4 mRNA in the pathogenic haplotype of FSHD.

Authors:  Natoya Peart; Eric J Wagner
Journal:  Hum Genet       Date:  2017-05-24       Impact factor: 4.132

4.  Biallelic FRA10AC1 variants cause a neurodevelopmental disorder with growth retardation.

Authors:  Leonie von Elsner; Guoliang Chai; Pauline E Schneeberger; Frederike L Harms; Christian Casar; Minyue Qi; Malik Alawi; Ghada M H Abdel-Salam; Maha S Zaki; Florian Arndt; Xiaoxu Yang; Valentina Stanley; Maja Hempel; Joseph G Gleeson; Kerstin Kutsche
Journal:  Brain       Date:  2022-05-24       Impact factor: 15.255

5.  Cellular migration and invasion uncoupled: increased migration is not an inexorable consequence of epithelial-to-mesenchymal transition.

Authors:  Daneen Schaeffer; Jason A Somarelli; Gabi Hanna; Gregory M Palmer; Mariano A Garcia-Blanco
Journal:  Mol Cell Biol       Date:  2014-07-07       Impact factor: 4.272

6.  Fluorescence-based alternative splicing reporters for the study of epithelial plasticity in vivo.

Authors:  Jason A Somarelli; Daneen Schaeffer; Reggie Bosma; Vivian I Bonano; Jang Wook Sohn; Gabor Kemeny; Abhinav Ettyreddy; Mariano A Garcia-Blanco
Journal:  RNA       Date:  2012-11-26       Impact factor: 4.942

7.  Cancer-associated splicing variant of tumor suppressor AIMP2/p38: pathological implication in tumorigenesis.

Authors:  Jin Woo Choi; Dae Gyu Kim; Al-Eum Lee; Hye Rim Kim; Jin Young Lee; Nam Hoon Kwon; Young Kee Shin; Soon-Kyung Hwang; Seung-Hee Chang; Myung-Haing Cho; Yoon-La Choi; Jhingook Kim; Seung Hyun Oh; Bora Kim; Soo-Youl Kim; Hyo-Sung Jeon; Jae Yong Park; Hyunseok Peter Kang; Bum Joon Park; Jung Min Han; Sunghoon Kim
Journal:  PLoS Genet       Date:  2011-03-31       Impact factor: 5.917

8.  Alternative Splicing of Fibroblast Growth Factor Receptor IgIII Loops in Cancer.

Authors:  Klaus Holzmann; Thomas Grunt; Christine Heinzle; Sandra Sampl; Heinrich Steinhoff; Nicole Reichmann; Miriam Kleiter; Marlene Hauck; Brigitte Marian
Journal:  J Nucleic Acids       Date:  2011-12-12

9.  Identification of an exonic splicing silencer in exon 6A of the human VEGF gene.

Authors:  Rui Wang; Ronald G Crystal; Neil R Hackett
Journal:  BMC Mol Biol       Date:  2009-11-17       Impact factor: 2.946

10.  Tat-SF1 is not required for Tat transactivation but does regulate the relative levels of unspliced and spliced HIV-1 RNAs.

Authors:  Heather B Miller; Kevin O Saunders; Georgia D Tomaras; Mariano A Garcia-Blanco
Journal:  PLoS One       Date:  2009-05-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.